NCI's Srivastava Named Brufsky Awardee for Pancreatic Cancer Research
Dr. Sudhir Srivastava, chief of the cancer biomarkers research group in the Division of Cancer Prevention, National Cancer Institute, has been named 2023 recipient of the Ruth C. Brufsky Award for Excellence in Clinical Research in Pancreatic Cancer.
The award, announced by the Collaborative Alliance for Pancreatic Education and Research, will be presented at PancreasFest, an annual meeting of pancreas physicians and translational researchers who convene during the last week of July to find new ways of working together to improve patient care.
The Brufsky family endows a fund to support clinical research in pancreatic cancer and to underwrite a yearly lecture from a nationally prominent pancreatic cancer expert.
Srivastava will receive the award on July 28 in Pittsburgh.